Phase One Medical

Phase One Medical specialises in implantable double-lumen haemodialysis catheters. These devices are specifically designed to provide long-term vascular access for patients undergoing chronic dialysis. The primary product in their portfolio is the Symetrex catheter, which comes in multiple configurations to suit different patient needs, including both standard and extended-duration use.

Phase One Medical is headquartered in the United States. The company’s location ensures compliance with US regulatory standards, which govern the design, manufacturing, and distribution of its medical devices.

Phase One Medical’s haemodialysis catheters fall under the Class II category of medical devices in the US. This classification applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as the Symetrex catheter. Class II devices are authorised through the FDA’s 510(k) premarket notification process.

Phase One Medical’s devices are listed in the FDA’s 510(k) registry, which tracks premarket notifications for Class II medical devices. Additionally, their products are included in the FDA’s Unique Device Identifier (UDI) system, ensuring traceability and compliance with US regulatory requirements. These listings help healthcare providers and regulators verify the authorised status of specific devices like the Symetrex catheter.

The 510(k) pathway is used for Class II devices like Phase One Medical’s Symetrex catheter because it demonstrates that the device is substantially equivalent to a legally marketed predicate device. This means the new device has the same intended use, technological characteristics, and performance as an existing authorised device, ensuring it meets necessary safety and effectiveness standards without requiring the more rigorous premarket approval process.